The occurrence of SV40-Neutralizing antibodies in sera of patients with genitourinary carcinoma.
D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis*; D001943:Breast Neoplasms / Q000276:immunology; D002295:Carcinoma, Transitional Cell / Q000276:immunology; D003429:Cross Reactions; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007106:Immune Sera; D007674:Kidney Diseases / Q000276:immunology; D008223:Lymphoma / Q000276:immunology; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009500:Neutralization Tests; D010412:Penile Neoplasms / Q000276:immunology; D011054:Poliovirus Vaccine, Inactivated; D011469:Prostatic Diseases / Q000276:immunology; D011471:Prostatic Neoplasms / Q000276:immunology; D011863:Radioimmunoassay; D012004:Rectal Neoplasms / Q000276:immunology; D013539:Simian virus 40 / Q000276:immunology*; D013736:Testicular Neoplasms / Q000276:immunology; D001749:Urinary Bladder Neoplasms / Q000276:immunology; D014565:Urogenital Neoplasms / Q000276:immunology*; D002583:Uterine Cervical Neoplasms / Q000276:immunology; D014611:Vaccination; D014860:Warts / Q000276:immunology
D000906:Antibodies; D007106:Immune Sera; D011054:Poliovirus Vaccine, Inactivated